|
Status |
Public on Jun 25, 2013 |
Title |
Before treatment (week 0) IBDB39 |
Sample type |
RNA |
|
|
Source name |
PBMC
|
Organism |
Homo sapiens |
Characteristics |
cell type: PBMC subject: Patient 11 response: R - responder treatment: Before treatment time: week 0 disease state: Crohn's disease
|
Treatment protocol |
Treatment was infliximab infusion at week 0 and at week 2.
|
Extracted molecule |
total RNA |
Extraction protocol |
Peripheral blood momonuclear cells were separated by Ficoll gradient centrifugation.
|
Label |
biotin
|
Label protocol |
Ambion WT Expression Kit (Applied Biosystems) and GeneChip WT Terminal Labeling and Control Kit (Affymetrix) were used for amplifying and labeling 250 ng of RNA samples.
|
|
|
Hybridization protocol |
Samples were hybridized at 45 degrees Celsius for 16 hours and then standard washing protocol was performed using GeneChip Fluidics Station 450.
|
Scan protocol |
Arrays were scanned on GeneChip Scanner 7G (Affymetrix).
|
Data processing |
Gene Spring GX 10 was used for data analysis, CEL files were imported using RMA algorithm and median normalization was performed. CHP files were generated using Affymetrix Expression Control.
|
|
|
Submission date |
Nov 14, 2012 |
Last update date |
Jun 25, 2013 |
Contact name |
Bertalan Mesko |
E-mail(s) |
berci.mesko@gmail.com
|
Organization name |
University of Debrecen
|
Department |
Department of Biochemistry and Molecular Biology
|
Lab |
Nuclear Hormone Receptor Research Laboratory
|
Street address |
Egyetem tér 1.
|
City |
Debrecen |
ZIP/Postal code |
4012 |
Country |
Hungary |
|
|
Platform ID |
GPL6244 |
Series (1) |
GSE42296 |
Distinct, non-overlapping gene panels of peripheral blood gene expression predict response to infliximab therapy in rheumatoid arthritis and Crohn's disease |
|